[Alefacept (Amevive(R)) for the treatment of severe psoriasis]
Danish Centre for Evaluation and Health Technology Assessment
Record ID 32005000558
Danish
Details
Project Status:
Completed
Year Published:
2003
URL for published report:
http://www.sst.dk/Udgivelser/2003/Alefacept%20Amevive%20mod%20moderat%20til%20svaer%20psoriasis.aspx
URL for additional information:
http://www.sst.dk/English/DACEHTA/Publications_alphabetical_order/Alefacept_for_the_treatment_of_severe_psoriasis.aspx
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Denmark
MeSH Terms
- Chronic Disease
- Immunosuppressive Agents
- Psoriasis
- Recombinant Fusion Proteins
Contact
Organisation Name:
Danish Centre for Evaluation and Health Technology Assessment
Contact Address:
National Board of Health, PO Box 1881, Islands Brygge 67, DK-2300 Copenhagen S, Denmark. Tel: 45 72 22 74 48; Fax: 45 72 22 74 07/67
Contact Name:
dacehta@sst.dk
Contact Email:
dacehta@sst.dk
Copyright:
Danish Centre for Evaluation and Health Technology Assessment (DACEHTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.